Featured Research

from universities, journals, and other organizations

Study helps patients make the most informed surgical decision

Date:
September 18, 2013
Source:
American Society of Anesthesiologists (ASA)
Summary:
Having the right tool to estimate surgical risk in patients at high risk for complications and death during and after surgery is crucially important, according to a study in the October issue of Anesthesiology.

Having the right tool to estimate surgical risk in patients at high risk for complications and death during and after surgery is crucially important, according to a study in the October issue of Anesthesiology. In a comprehensive review of risk stratification systems, researchers evaluated many tools, identifying two as most accurate predictors of short-term mortality, but both have limitations.

"Understanding the risk of a surgical procedure is essential so that patient consent can be fully informed and clinical teams can tailor perioperative care to the individual needs of each patient," said Suneetha Ramani Moonesinghe, M.B.B.S., M.R.C.P., FRCA, FFICM, Surgical Outcomes Research Centre, University College Hospital, London. "While there are many systems available to estimate surgical risk, few have been rigorously tested for accuracy, and even the best systems have limitations."

Risk stratification tools are mathematical equations that offer the most widely available and resource-efficient means of predicting patient risk. The information gathered from these tools should be shared with patients so they can make the most informed decision about their surgery. For example, if a patient is at high risk for kidney failure during surgery, they need to be aware that they could be on dialysis for the rest of their life. Additionally, if there is high risk for a major complication or death, the patient may want to still proceed with the surgery, but may also want to discuss advanced directives and health care plans in view of this information.

For high-risk patients, the surgical team can opt to change the planned procedure to a less severe operation, delay surgery until risk factors for poor outcome have been treated, manage the patient after surgery in a critical care unit or possibly even decide to cancel the surgery if the operation was not life-saving (cancer surgery), but life-improving (joint replacement), according to Dr. Moonesinghe.

Study authors researched medical literature to determine which tools were the most accurate predictors, when tested in studies of patient populations undergoing a variety of surgical procedures. Twenty-seven studies evaluating 34 risk stratification tools were identified.

The study found two systems to be the most accurate predictors of short-term mortality: the Portsmouth Physiological and Operative Scoring System for the enUmeration of Morbidity and Mortality (P-POSSUM) and the Surgical Risk Scale. However, the study notes that both systems have limitations. The P-POSSUM system includes some data which are only available during and after surgery, thus limiting its use for preoperative consultation. Also, the Surgical Risk Scale, while it is an entirely preoperative predictor, has only been tested in the United Kingdom.

"The ideal tool would include data which is available in entirety before the surgical procedure, would be simple and quick to use and provide a percentage estimate of the short-term risk of death following surgery, but such a tool remains elusive," said Dr. Moonesinghe. "As the health care world embraces the concept of 'shared decision making' between patients and doctors, a risk stratification tool that enables patients to understand their complete operative risk would be hugely valuable."

Risk stratification tools are one of many physician anesthesiologists use as the perioperative physician before, during and after surgery in the operating room. Their role includes evaluating the patient before surgery consulting with the surgical team, providing pain control and supporting life functions during surgery, supervising care after surgery and discharging the patient from the recovery unit.


Story Source:

The above story is based on materials provided by American Society of Anesthesiologists (ASA). Note: Materials may be edited for content and length.


Cite This Page:

American Society of Anesthesiologists (ASA). "Study helps patients make the most informed surgical decision." ScienceDaily. ScienceDaily, 18 September 2013. <www.sciencedaily.com/releases/2013/09/130918175555.htm>.
American Society of Anesthesiologists (ASA). (2013, September 18). Study helps patients make the most informed surgical decision. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2013/09/130918175555.htm
American Society of Anesthesiologists (ASA). "Study helps patients make the most informed surgical decision." ScienceDaily. www.sciencedaily.com/releases/2013/09/130918175555.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins